论文部分内容阅读
纯化的Vero细胞狂犬病疫苗（PVRV）由狂犬病病毒Wistar rabies PM/W 138-1503-3M株制备,作者在泰国的两所学校用PVRV对190名儿童分别采用皮下（ID）和肌肉（IM）法进行预防接种。ID法是在三角肌区皮下注射0.1ml疫苗,IM法则是三角肌肌肉注射0.5ml疫苗,均于0、7、28天进行初免。分别于免前、免后56天、6个月和1年抽取3～5ml静脉血。第1年采血后每人均按初免方法加强1针,并于加强后7天、6个月、1年和2年采血,用快速荧光灶抑制试验（RFFIT）检测血清中和抗体滴度,同时观察不良反应。
The purified Vero cell rabies vaccine (PVRV) was prepared from the rabies virus Wistar rabies PM / W 138-1503-3M strain and the authors used subcutaneous (ID) and muscle (IM) methods in 190 children at two schools in Thailand with PVRV Vaccination. ID method is the subcutaneous injection of 0.1ml deltoid muscle vaccine, IM law is the intramuscular injection of 0.5ml deltoid vaccine, were in 0,7,28 days for initial release. Respectively, free, 56 days after the exemption, 6 months and 1 year to extract 3 ~ 5ml venous blood. After the first year of blood collection, each person was boosted with 1 needle according to the initial priming method, and the blood samples were collected at 7 days, 6 months, 1 year and 2 years after the enhancement. The serum neutralizing antibody titer was detected by RFFIT, Adverse reactions were observed at the same time.